From: Association of retroperitoneal fibrosis with malignancy and its outcomes
Case | Sex | Age at RPF diagnosis | Age at malignancy diagnosis | Malignancy site | Malignancy type | Stage (TNM) |
---|---|---|---|---|---|---|
1 | M | 68 | 68 | Lung | Adenocarcinoma | I |
2 | M | 76 | 76 | Lung | NSCLC | IV |
3 | M | 52 | 52 | Stomach | Adenocarcinoma | IV |
4 | M | 67 | 67 | Stomach | Adenocarcinoma | IV |
5 | F | 82 | 82 | Stomach | Adenocarcinoma | – |
6 | M | 68 | 67 | Small intestine | GIST | IV |
7 | M | 49 | 49 | Colon | Adenocarcinoma | IIA |
8 | M | 52 | 51 | Colon | Adenocarcinoma | IIIB, |
9 | M | 54 | 54 | Pancreas | Adenocarcinoma | – |
10 | M | 78 | 78 | Pancreas | Adenocarcinoma | – |
11 | M | 47 | 46 | Kidney | Clear cell | II |
12 | M | 64 | 64 | Kidney | Clear cell | I |
13 | M | 51 | 51 | Renal pelvis | TCC | IV |
14* | F | 79 | 79 | Renal pelvis | TCC | III |
15 | F | 77 | 78 | Renal pelvis | TCC | IV |
16 | F | 75 | 75 | GB | Adenocarcinoma | – |
17 | M | 67 | 67 | Bladder | TCC | I |
18† | F | 67 | 67 | Bone | Adenocarcinoma | IV |
19 | M | 74 | 74 | Prostate | Adenocarcinoma | II |
20 | M | 73 | 73 | Peritoneum | MM | III |
21 | F | 64 | 64 | Peritoneum | NHL | III |
22 | F | 75 | 75 | Lymph node | Squamous | IV |
23 | F | 50 | 49 | Thyroid | PTC | I |
24‡ | M | 67 | 69 | Lung | Adenocarcinoma | I |
25 | M | 53 | 51 | Stomach | Signet ring | I |
26 | M | 68 | 67 | Colon | Adenocarcinoma | IIIB |
27§ | M | 78 | 80 | Rectum | Adenocarcinoma | – |
28 | M | 40 | 43 | Peritoneum | Liposarcoma | IIIB |
29 | F | 42 | 39 | Cervix uteri | Adeno | II |
30 | M | 49 | 52 | BM | MDS | – |
31‡ | M | 67 | 71 | BM | MM | – |
32† | F | 67 | 62 | Breast | Adenocarcinoma | II |
33 | F | 66 | 72 | Thyroid | PTC | II |
34¶ | M | 71 | 63 | Larynx | Squamous | IV |
35¶ | M | 71 | 60 | Lung | Squamous | I |
36 | M | 65 | 82 | Stomach | Adenocarcinoma | I |
37§ | M | 78 | 71 | Stomach | Adenocarcinoma | I |
38 | F | 64 | 45 | Skin | Basal cell | I |